Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations
Carl Roos, David Dahlgren, Staffan Berg, et al.
Molecular Pharmaceutics (2017) Vol. 14, Iss. 12, pp. 4233-4242
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 289-331
Open Access | Times Cited: 114
Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs
Filippos Kesisoglou, Michael S. Wang, Kendra Galipeau, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 108, Iss. 9, pp. 2917-2925
Closed Access | Times Cited: 64
Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles
Akshay Narula, Rayan Sabra, Na Li
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3085-3099
Open Access | Times Cited: 29
Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs
Aaron M. Stewart, Michael Graß
Molecular Pharmaceutics (2019) Vol. 17, Iss. 1, pp. 180-189
Open Access | Times Cited: 46
In vitro and in situ experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements
Jenifer García-Fernández, Daniel Turiel, Jörg Bettmer, et al.
Nanotoxicology (2020) Vol. 14, Iss. 3, pp. 388-403
Closed Access | Times Cited: 42
The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs
David Dahlgren, Christian Roos, Pernilla Johansson, et al.
International Journal of Pharmaceutics (2018) Vol. 547, Iss. 1-2, pp. 158-168
Closed Access | Times Cited: 45
The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro–in vivo correlation of nanocrystals
Masaaki Imono, Hiromasa Uchiyama, Shinpei Yoshida, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 146, pp. 84-92
Closed Access | Times Cited: 38
Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size
Keisuke Ueda, Lynne S. Taylor
Journal of Controlled Release (2020) Vol. 330, pp. 229-243
Closed Access | Times Cited: 35
Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?
Kaijie Qian, Lorenzo Stella, David S. Jones, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 889-889
Open Access | Times Cited: 28
Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid–Liquid Phase Separation
Etsushi Yoshikawa, Keisuke Ueda, Rei Hakata, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1745-1755
Closed Access | Times Cited: 4
The Particle Drifting Effect: A Combined Function of Colloidal and Drug Properties
Da Hye Yang, Saeed Najafian, Bodhisattwa Chaudhuri, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 3
Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport
David Dahlgren, Christian Roos, Anders Lundqvist, et al.
International Journal of Pharmaceutics (2018) Vol. 549, Iss. 1-2, pp. 239-248
Closed Access | Times Cited: 31
Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model
David Dahlgren, Christian Roos, Karsten Peters, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 31-37
Closed Access | Times Cited: 26
Combining biorelevant in vitro and in silico tools to simulate and better understand the in vivo performance of a nano-sized formulation of aprepitant in the fasted and fed states
Chara Litou, Nikunjkumar Patel, David B. Turner, et al.
European Journal of Pharmaceutical Sciences (2019) Vol. 138, pp. 105031-105031
Open Access | Times Cited: 26
Development of oral aprepitant-loaded chitosan–polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation
Nazlı Erdoğar, Safiye Akkın, Thorbjørn Terndrup Nielsen, et al.
Journal of Pharmaceutical Investigation (2021) Vol. 51, Iss. 3, pp. 297-310
Closed Access | Times Cited: 21
Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles
Naho Hanada, Kenjirou Higashi, Zhijing Zhao, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 122959-122959
Closed Access | Times Cited: 9
A pharmacological overview of aprepitant for the prevention of postoperative nausea and vomiting
A. Padilla, Ashraf S. Habib
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 6, pp. 491-505
Closed Access | Times Cited: 9
Jejunal absorption of aprepitant from nanosuspensions: Role of particle size, prandial state and mucus layer
Christian Roos, David Dahlgren, Erik Sjögren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 132, pp. 222-230
Closed Access | Times Cited: 25
Mechanistic modelling of intestinal drug absorption – The in vivo effects of nanoparticles, hydrodynamics, and colloidal structures
Christian Roos, Jan Westergren, David Dahlgren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 133, pp. 70-76
Closed Access | Times Cited: 25
Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs
Naoya Matsumura, Shun Hayashi, Yoshiyuki Akiyama, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 3, pp. 1403-1416
Closed Access | Times Cited: 24
Comparisons of in Vitro Models to Evaluate the Membrane Permeability of Amorphous Drug Nanoparticles
Rayan Sabra, Akshay Narula, Lynne S. Taylor, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 9, pp. 3412-3428
Closed Access | Times Cited: 13
Combined effects of the drug distribution and mucus diffusion properties of self-microemulsifying drug delivery systems on the oral absorption of fenofibrate
Yushi Sunazuka, Keisuke Ueda, Kenjirou Higashi, et al.
International Journal of Pharmaceutics (2018) Vol. 546, Iss. 1-2, pp. 263-271
Closed Access | Times Cited: 23
Time-dependent effects on small intestinal transport by absorption-modifying excipients
David Dahlgren, Christian Roos, Anders Lundqvist, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2018) Vol. 132, pp. 19-28
Closed Access | Times Cited: 23
Effect of molecular weight of hypromellose on mucin diffusion and oral absorption behavior of fenofibrate nanocrystal
Keisuke Ueda, Takaaki Iwai, Yushi Sunazuka, et al.
International Journal of Pharmaceutics (2019) Vol. 564, pp. 39-47
Closed Access | Times Cited: 21
Rat intestinal drug permeability: A status report and summary of repeated determinations
Ilse R. Dubbelboer, David Dahlgren, Erik Sjögren, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2019) Vol. 142, pp. 364-376
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top